Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025
Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—including programs LBL–034 and LBL–076—have been accepted for presentation at ...
SYDNEY, Nov. 4, 2025 /PRNewswire/ -- Usher in the year-end season with exclusive flight, hotel and attraction deals [1] from Trip.com from 4 to 16 November 2025, both dates inclusive. Get ready to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results